rs374862218
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_182961.4(SYNE1):c.8311G>A(p.Val2771Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,614,024 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_182961.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SYNE1 | NM_182961.4 | c.8311G>A | p.Val2771Ile | missense_variant | Exon 54 of 146 | ENST00000367255.10 | NP_892006.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SYNE1 | ENST00000367255.10 | c.8311G>A | p.Val2771Ile | missense_variant | Exon 54 of 146 | 1 | NM_182961.4 | ENSP00000356224.5 | ||
SYNE1 | ENST00000423061.6 | c.8332G>A | p.Val2778Ile | missense_variant | Exon 54 of 146 | 1 | ENSP00000396024.1 | |||
SYNE1 | ENST00000461872.6 | n.8529G>A | non_coding_transcript_exon_variant | Exon 52 of 55 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152148Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000716 AC: 18AN: 251284Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135794
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1461876Hom.: 0 Cov.: 32 AF XY: 0.0000261 AC XY: 19AN XY: 727240
GnomAD4 genome AF: 0.000197 AC: 30AN: 152148Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74322
ClinVar
Submissions by phenotype
not provided Uncertain:3
Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is higher than would generally be expected for pathogenic variants in this gene (http://gnomad.broadinstitute.org). Computational tools predict that this variant is not damaging. -
- -
The V2778I variant in the SYNE1 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The V2778I variant is observed in 5/10406 (0.048%) alleles from individuals of African background, in the ExAC dataset (Lek et al., 2016). The V2778I variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is not conserved. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret V2778I as a variant of uncertain significance. -
Inborn genetic diseases Uncertain:1
The c.8332G>A (p.V2778I) alteration is located in exon 54 (coding exon 53) of the SYNE1 gene. This alteration results from a G to A substitution at nucleotide position 8332, causing the valine (V) at amino acid position 2778 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant Uncertain:1
This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 2778 of the SYNE1 protein (p.Val2778Ile). This variant is present in population databases (rs374862218, gnomAD 0.09%). This variant has not been reported in the literature in individuals affected with SYNE1-related conditions. ClinVar contains an entry for this variant (Variation ID: 282323). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at